Page last updated: 2024-08-24

duloxetine hydrochloride and Liver Dysfunction

duloxetine hydrochloride has been researched along with Liver Dysfunction in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Acharya, N; Heinloth, AN; Kuritzky, L; Regev, A; Robinson, M; Strombom, I; Wernicke, JF; Wohlreich, MM1
Acharya, N; D'Souza, DN; DiPietro, N; Gahimer, JL; Strombom, I; Uetrecht, JP; Wernicke, J1
D'Souza, DN; Henck, JW; Knadler, MP; Murray, I; Pangallo, B; Uetrecht, JP; Wang, F; Wernicke, J1

Reviews

3 review(s) available for duloxetine hydrochloride and Liver Dysfunction

ArticleYear
Answers to the most common questions about the hepatic safety profile of duloxetine.
    Postgraduate medicine, 2008, Volume: 120, Issue:2

    Topics: Antidepressive Agents; Chemical and Drug Induced Liver Injury; Depressive Disorder; Drug Approval; Drug Labeling; Duloxetine Hydrochloride; Humans; Liver Diseases; Risk Assessment; Thiophenes; United States

2008
Hepatic effects of duloxetine-II: spontaneous reports and epidemiology of hepatic events.
    Current drug safety, 2008, Volume: 3, Issue:2

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Adverse Drug Reaction Reporting Systems; Age Distribution; Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Child; Consumer Product Safety; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Humans; Liver; Liver Diseases; Male; Middle Aged; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sex Distribution; Thiophenes; Young Adult

2008
Hepatic effects of duloxetine-I: non-clinical and clinical trial data.
    Current drug safety, 2008, Volume: 3, Issue:2

    Topics: Adrenergic Uptake Inhibitors; Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Bilirubin; Biomarkers; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Consumer Product Safety; Drug Evaluation, Preclinical; Duloxetine Hydrochloride; Humans; Liver; Liver Diseases; Risk Assessment; Risk Factors; Selective Serotonin Reuptake Inhibitors; Species Specificity; Thiophenes

2008